Status:
COMPLETED
Mantra Meditation in Subjects That Have Chronically Impaired Attention After Stroke
Lead Sponsor:
Cheryl Carrico
Conditions:
Stroke Sequelae
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
There is an evidence gap on whether meditation may improve behaviorally measured attention after stroke, but preliminary research is promising. This study is the first-ever investigation of whether ma...
Detailed Description
The study is non-concurrent, multiple-baseline, across-subjects, single-case research design (SCRD). The central hypothesis is that mantra meditation (independent variable) will be associated with imp...
Eligibility Criteria
Inclusion
- Inclusion Criteria.
- Adults between the ages of 18 and 70
- Chronic, non-lacunar, right-hemisphere stroke (i.e., sustained at \>12 months prior to date of clinical screen)
- Severely impaired attention defined as 5 or more errors of commission on the SARTfixed
- Intact consent capacity with no evidence of dementia, defined as a score of 100% correct answer rate on University of California, San Diego Brief Assessment of Capacity to Consent (UBACC).
- Right-handed dominance as well as sufficient movement and vision function for testing (use of computer mouse, keyboard, and monitor)
- English language fluency and reading comprehension at least at 6th grade level
- Exclusion Criteria.
- Depression defined as a score of \>10 on Beck Depression Inventory, Short Form (BDI-SF)
- Current or significant history of substance abuse
- In the 3 months preceding enrollment, change in medications that impact neuroplasticity
- Current participation in any other research study, cognitive rehabilitation, meditation, or mental training program, including commercial brain-training programs
- Neurological disorder other than stroke (e.g., Parkinson's disorder; multiple sclerosis; traumatic brain injury)
- Spatial attention deficit (unilateral neglect) defined as a score of 51 or fewer cancellations on the Star Cancellation Test.
- According to the clinical judgement of the PI or her authorized designee, any other functional impairment which would significantly deter comprehension and/or execution of the requirements of the trial, such as aphasia, hearing deficit, or mobility deficit restricting navigation to, from, and within the research site. Subjects must be able to provide their own transportation to and from the study site.
- Uncontrolled or severe mental or cognitive disorder with low psychosocial functioning, such as untreated schizophrenia, bipolar disorder, or autism
Exclusion
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 9 2018
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03229902
Start Date
May 1 2017
End Date
March 9 2018
Last Update
June 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40504